221 related articles for article (PubMed ID: 28131849)
1. Characterization and biocompatibility evaluation of cutaneous formulations containing lipid nanoparticles.
Eiras F; Amaral MH; Silva R; Martins E; Lobo JMS; Silva AC
Int J Pharm; 2017 Mar; 519(1-2):373-380. PubMed ID: 28131849
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the biocompatibility and skin hydration potential of vitamin E-loaded lipid nanosystems formulations: In vitro and human in vivo studies.
Vaz S; Silva R; Amaral MH; Martins E; Sousa Lobo JM; Silva AC
Colloids Surf B Biointerfaces; 2019 Jul; 179():242-249. PubMed ID: 30974262
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Emulgel and Nanostructured Lipid Carrier-Based Gel Formulations for Transdermal Administration of Ibuprofen: Characterization, Mechanical Properties, and Ex-Vivo Skin Permeation.
Yılmaz Usta D; Teksin ZS; Tugcu-Demiroz F
AAPS PharmSciTech; 2024 May; 25(5):124. PubMed ID: 38822143
[TBL] [Abstract][Full Text] [Related]
4. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A
Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401
[TBL] [Abstract][Full Text] [Related]
5. Formulations based on solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for cutaneous use: A review.
Garcês A; Amaral MH; Sousa Lobo JM; Silva AC
Eur J Pharm Sci; 2018 Jan; 112():159-167. PubMed ID: 29183800
[TBL] [Abstract][Full Text] [Related]
6. Development of ibuprofen-loaded nanostructured lipid carrier-based gels: characterization and investigation of in vitro and in vivo penetration through the skin.
Sütő B; Berkó S; Kozma G; Kukovecz Á; Budai-Szűcs M; Erős G; Kemény L; Sztojkov-Ivanov A; Gáspár R; Csányi E
Int J Nanomedicine; 2016; 11():1201-12. PubMed ID: 27099487
[TBL] [Abstract][Full Text] [Related]
7. Effect of compositions in nanostructured lipid carriers (NLC) on skin hydration and occlusion.
Loo Ch; Basri M; Ismail R; Lau H; Tejo B; Kanthimathi M; Hassan H; Choo Y
Int J Nanomedicine; 2013; 8():13-22. PubMed ID: 23293516
[TBL] [Abstract][Full Text] [Related]
8. Nanostructured lipid carriers (NLC) based controlled release topical gel of clobetasol propionate: design and in vivo characterization.
Nagaich U; Gulati N
Drug Deliv Transl Res; 2016 Jun; 6(3):289-98. PubMed ID: 27072979
[TBL] [Abstract][Full Text] [Related]
9. A synergistic approach of adapalene-loaded nanostructured lipid carriers, and vitamin C co-administration for treating acne.
Jain A; Garg NK; Jain A; Kesharwani P; Jain AK; Nirbhavane P; Tyagi RK
Drug Dev Ind Pharm; 2016; 42(6):897-905. PubMed ID: 26577703
[TBL] [Abstract][Full Text] [Related]
10. Comparison of liposomal and NLC (nanostructured lipid carrier) formulations for improving the transdermal delivery of oxaprozin: Effect of cyclodextrin complexation.
Mennini N; Cirri M; Maestrelli F; Mura P
Int J Pharm; 2016 Dec; 515(1-2):684-691. PubMed ID: 27825863
[TBL] [Abstract][Full Text] [Related]
11. Influence of nanostructured lipid carriers (NLC) on the physical properties of the Cutanova Nanorepair Q10 cream and the in vivo skin hydration effect.
Pardeike J; Schwabe K; Müller RH
Int J Pharm; 2010 Aug; 396(1-2):166-73. PubMed ID: 20541000
[TBL] [Abstract][Full Text] [Related]
12. Development and characterization of new and scalable topical formulations containing N-acetyl-d-glucosamine-loaded solid lipid nanoparticles.
Marto J; Sangalli C; Capra P; Perugini P; Ascenso A; Gonçalves L; Ribeiro H
Drug Dev Ind Pharm; 2017 Nov; 43(11):1792-1800. PubMed ID: 28581831
[TBL] [Abstract][Full Text] [Related]
13. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations.
Müller RH; Radtke M; Wissing SA
Adv Drug Deliv Rev; 2002 Nov; 54 Suppl 1():S131-55. PubMed ID: 12460720
[TBL] [Abstract][Full Text] [Related]
14. Impact of lipid dynamic behavior on physical stability, in vitro release and skin permeation of genistein-loaded lipid nanoparticles.
Andrade LM; de Fátima Reis C; Maione-Silva L; Anjos JL; Alonso A; Serpa RC; Marreto RN; Lima EM; Taveira SF
Eur J Pharm Biopharm; 2014 Sep; 88(1):40-7. PubMed ID: 24816130
[TBL] [Abstract][Full Text] [Related]
15. Development and characterization of a novel controlled release drug delivery system based on nanostructured lipid carriers gel for meloxicam.
Khurana S; Jain NK; Bedi PM
Life Sci; 2013 Nov; 93(21):763-72. PubMed ID: 24113071
[TBL] [Abstract][Full Text] [Related]
16. Lipid nanoparticles as carrier for octyl-methoxycinnamate: in vitro percutaneous absorption and photostability studies.
Puglia C; Bonina F; Rizza L; Blasi P; Schoubben A; Perrotta R; Tarico MS; Damiani E
J Pharm Sci; 2012 Jan; 101(1):301-11. PubMed ID: 21905033
[TBL] [Abstract][Full Text] [Related]
17. Tadalafil-loaded nanostructured lipid carriers using permeation enhancers.
Baek JS; Pham CV; Myung CS; Cho CW
Int J Pharm; 2015 Nov; 495(2):701-9. PubMed ID: 26423175
[TBL] [Abstract][Full Text] [Related]
18. Heptapeptide-loaded solid lipid nanoparticles for cosmetic anti-aging applications.
Suter F; Schmid D; Wandrey F; Zülli F
Eur J Pharm Biopharm; 2016 Nov; 108():304-309. PubMed ID: 27343822
[TBL] [Abstract][Full Text] [Related]
19. Nanostructured lipid carriers (NLCs) versus solid lipid nanoparticles (SLNs) for topical delivery of meloxicam.
Khalil RM; Abd-Elbary A; Kassem MA; Ghorab MM; Basha M
Pharm Dev Technol; 2014 May; 19(3):304-14. PubMed ID: 23528038
[TBL] [Abstract][Full Text] [Related]
20. Design and ocular tolerance of flurbiprofen loaded ultrasound-engineered NLC.
Gonzalez-Mira E; Egea MA; Garcia ML; Souto EB
Colloids Surf B Biointerfaces; 2010 Dec; 81(2):412-21. PubMed ID: 20719479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
